Nano-fertilizers present a revolutionary advancement over conventional fertilizers, offering significant benefits such as controlled release, efficient use of nutrients, and less pollution. Nano-fertilizers can promote photosynthesis in plants, improve the photosynthetic efficiency of crops, increase the biomass of plants, thereby increasing crop yields through their special physiochemical properties. Nanotechnology as a cutting-edge innovation in agriculture and represent a promising and cost-effective alternative to conventional fertilizers for increasing the productivity of the world's food supply.

Covering a decade of research, this review dissects how engineers build force-feedback bilateral teleoperation, mapping four channel architectures and seven control algorithms—passivity, energy-bounding, model-predictive and more—each aimed at stability and transparency despite network delays. It spotlights emerging themes such as AI-adaptive gains and multimodal haptics, and ends by sketching frontier scenarios—from remote radioactive handling to dexterous robotic microsurgery—that will stretch the next generation of designs.

In a pioneering study, researchers treated rice seeds with various concentrations of paclobutrazol prior to planting, aiming not only to enhance seedling growth but also to reduce the incidence of bakanae disease in rice

Thirty years on, miRNA-based diagnostic and therapeutic agents for HCC remain a work-in-progress (WIP) and no current miRNA HCC clinical trial has progressed to phase 4. The question remains why this is the case after 30 years and what is the way forward. The major findings and contribution of this paper are that it illustrates the complexity of the miRNA interactome in HBV-HCC in all cellular processes.

The way a drug works and what it targets in the body are key factors in how effectively it can kill harmful cells. This work looks at a group of important proteins called receptor tyrosine kinases, which are often involved in diseases like cancer. Scientists have found that certain chemical structures—called heterocycles, such as pyrimidine, thiazole, imidazole, indole, acridone, and triazine—can be used to make drugs that target these proteins. With some changes, these compounds could also be designed to affect other disease pathways in the future.